Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › formoterol

formoterol

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of formoterol

22 trials tracked of formoterol: 12 in phase 3 or 4 and 6 with published results. The most-cited published study has 174 citations.

22Trials tracked
12Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 3 12 Phase 2 7 Other / NA 3
  1. Phase 3 Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination Completed · 174 cited
  2. Phase 3 Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Completed · 147 cited
  3. Phase 3 Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) Completed · 64 cited
  4. Phase 3 Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Completed · 33 cited
  5. Phase 3 Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Completed · 30 cited
  6. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 18 cited
Show 16 more trials
  1. Phase 3 A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD Completed
  2. Phase 3 Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients Completed
  3. Phase 3 The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  4. Phase 3 Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I Completed
  5. Phase 3 Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II Completed
  6. Phase 3 Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control Completed
  7. Phase 2 LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Completed
  8. Phase 2 A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma Completed
  9. Phase 2 Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler® Completed
  10. Phase 2 Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199 Completed
  11. Phase 2 Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients Completed
  12. Phase 2 Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Completed
  13. Phase 2 A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  14. N/A Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes. Completed
  15. N/A Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay Completed
  16. N/A COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers Completed

Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Anti-inflammatory reliever therapy outperforms SABA-only in asthma management
Diabetes & Endocrinology Sys. Review
Anti-inflammatory reliever therapy outperforms SABA-only in asthma management Doctors suggest using anti-inflammatory reliever therapy for better asthma control and safety
This narrative review compares anti-inflammatory reliever (AIR) therapy and SMART/MART with SABA-only bronchodilators for asthma. The author…
This review looks at asthma treatments. Using anti-inflammatory reliever therapy may help people breathe easier and stay safe compared to us…
Frontiers Jun 2, 2026
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance
Pulmonology & Critical Care FDA Approval
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance FDA approves new triple-combination inhaler Breztri Aerosphere for COPD.
The FDA approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for maintenance treatment of COPD. It is a triple-combin…
The FDA approved Breztri Aerosphere, a triple-combination inhaler, for the long-term treatment of chronic obstructive pulmonary disease (COP…
FDA May 2, 2026
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
Allergy & Immunology RCT
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma New Asthma Drug Cuts Attacks Without Recent Crisis
This phase 3 randomised, double-blind, double-dummy, parallel-group trial evaluated budesonide-glycopyrronium-formoterol fumarate dihydrate …
A new asthma combo therapy improves breathing and lowers severe flare-up risk for patients who haven't had a recent emergency room visit.
Apr 14, 2026
Pink vs. white inhaler actuators studied for asthma symptom perception in crossover trial
Allergy & Immunology Phase III
Pink vs. white inhaler actuators studied for asthma symptom perception in crossover trial Study compares pink and white asthma inhalers for how patients perceive symptoms
A phase IIIb randomized, double-blind, crossover trial in 78 adults with moderate to severe asthma compared identical beclomethasone/formote…
Asthma patients tried identical inhalers in pink or white to see if color changed how they perceived their symptoms and which device they pr…
CT.gov Mar 30, 2026